Form 8-K - Current report:
SEC Accession No. 0001193125-25-113275
Filing Date
2025-05-06
Accepted
2025-05-06 07:01:18
Documents
26
Period of Report
2025-05-05
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d941544d8k.htm   iXBRL 8-K 25338
2 EX-99.1 d941544dex991.htm EX-99.1 19410
3 EX-99.2 d941544dex992.htm EX-99.2 18260
7 GRAPHIC g941544ex99_1s10g1.jpg GRAPHIC 123379
8 GRAPHIC g941544ex99_1s1g1.jpg GRAPHIC 77215
9 GRAPHIC g941544ex99_1s2g1.jpg GRAPHIC 250615
10 GRAPHIC g941544ex99_1s3g1.jpg GRAPHIC 193017
11 GRAPHIC g941544ex99_1s4g1.jpg GRAPHIC 103331
12 GRAPHIC g941544ex99_1s5g1.jpg GRAPHIC 64978
13 GRAPHIC g941544ex99_1s6g1.jpg GRAPHIC 97734
14 GRAPHIC g941544ex99_1s7g1.jpg GRAPHIC 102281
15 GRAPHIC g941544ex99_1s8g1.jpg GRAPHIC 120330
16 GRAPHIC g941544ex99_1s9g1.jpg GRAPHIC 94910
17 GRAPHIC g941544g0506002055552.jpg GRAPHIC 3760
  Complete submission text file 0001193125-25-113275.txt   1898202

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA aldx-20250505.xsd EX-101.SCH 2874
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE aldx-20250505_lab.xml EX-101.LAB 17994
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aldx-20250505_pre.xml EX-101.PRE 11277
28 EXTRACTED XBRL INSTANCE DOCUMENT d941544d8k_htm.xml XML 3642
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36332 | Film No.: 25915177
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)